AI Citation Integrity in Medical Publishing: From Plausible References to Verified Sources

A citation can look real and still point to nothing.

It can carry a journal name.

A plausible author list.

A formatted DOI.

A date that fits.

A title that matches the surrounding claim.

And it can still be completely invented.

For medical publishers, this is no longer a marginal editorial integrity issue.

It is becoming a structural threat to the one asset medical publishing cannot afford to weaken:

confidence in the source.

The next standard is not whether an AI-generated citation looks plausible.

It is whether the cited source exists, matches trusted metadata and was used in a traceable workflow.

In short

AI citation integrity in medical publishing is not only about whether a reference is formatted correctly. It is about whether the cited source can be verified before it enters the published record.

A fabricated citation may look credible. It may include a plausible title, journal, author list, date or DOI-like string. But if the source does not exist, cannot be resolved, or does not match trusted metadata, the citation is not evidence. It is contamination.

The 2026 Lancet audit of biomedical literature shows why the problem is now structural. Fabricated references are not isolated anomalies. They can pass through AI-assisted writing, submission, review and publication workflows because many systems still treat references as text rather than verifiable source events.

At Citations Logic, we use the term usage evidence to describe rights-aware records that make AI content use visible, attributable and commercially actionable.

For medical publishers, the principle is sharper:

A citation should not only be cited.

It should be verified, matched to a trusted source record and logged as part of the workflow.

A plausible reference is not enough.

Medical publishing needs provable sources.

The number medical publishers cannot ignore

In May 2026, The Lancet published an audit of 2.5 million biomedical papers from PubMed Central’s Open Access subset.

The finding is hard to dismiss.

Among papers published in early 2026, approximately one in 277 contained at least one fabricated reference.

In 2023, the rate was approximately one in 2,828.

That is not citation noise.

That is a contamination curve.

Columbia researchers identified 4,046 fabricated citations across 2,810 papers. Many were not obvious mistakes. They were formatted. They were topical. They were plausible.

That is precisely the problem.

A fabricated reference that looks wrong gets caught.

A fabricated reference that looks right travels.

This is why AI usage evidence for publishers cannot remain a licensing-only discussion.

In medical publishing, evidence also means source integrity.

The real failure is the silence after detection

The most important number in the audit may not be the number of fabricated citations.

It may be what happened next.

The Lancet audit reported that, at the time of analysis, 98.4% of affected papers had received no publisher action.

No correction.

No retraction.

No visible integrity signal.

That turns a research integrity finding into a publishing infrastructure problem.

The issue is not only that AI systems can generate fabricated references.

The deeper issue is that many publishing workflows still treat references as text, not as verifiable source events.

In too many workflows, a reference is still just a string.

It renders.

It looks formatted.

It fits the bibliography.

It passes visually.

But nothing in the workflow necessarily asks whether the source exists, whether the metadata matches, whether the DOI or PMID resolves correctly, whether the source is accessible, whether the source has been corrected or retracted, or whether it was actually used in the AI-assisted output.

That gap was easier to tolerate when fabricated references were rare, manual and easier to spot.

It is not tolerable when generative AI can produce plausible-looking references at scale.

Why AI raises the stakes

Fabricated citations are not new.

AI did not invent the problem.

But AI changes the speed, volume and surface area of the risk.

Generative AI can produce a reference that satisfies the visual tests of legitimacy without any underlying source. AI-assisted writing, summarization, literature review and manuscript preparation increasingly sit upstream of the published record.

That means a fabricated reference can be created inside an AI workflow, then laundered into the literature through normal editorial channels.

Once it enters the record, it behaves like any other citation.

It can be retrieved.

It can be summarized.

It can support a downstream claim.

It can appear in a review.

It can influence a guideline.

It can be reabsorbed by another AI system.

The error compounds.

And at no point does the chain necessarily stop to ask the only question that matters:

Did this source ever exist?

That is why machine-readable provenance for reference publishers is becoming an operational control, not a trust slogan.

Medical publishers need source records that systems can check before fabricated references move downstream.

Why this is a medical publishing problem

Medical publishing has a different risk profile from general content publishing.

A weak citation in a consumer article is a quality problem.

A weak citation in medical literature can become an evidence problem.

A clinician does not manually verify every reference behind every review.

A guideline developer cannot reconstruct every citation trail.

A medical publisher cannot protect trust if the first warning signal arrives only after an article has entered downstream evidence workflows.

This is why fabricated references are not just an author misconduct issue.

They are a workflow verification issue.

A publisher’s authority does not come only from the words on the page.

It comes from the trust signals around those words: peer review, editorial governance, version control, corrections, retractions, metadata quality and provenance.

When a citation cannot be traced to a real, accessible, correctly versioned source, that authority erodes quietly.

Paper by paper.

Workflow by workflow.

Dataset by dataset.

From plausible references to verifiable source events

The old question was:

Does the citation look correct?

The new question is:

Can the cited source be verified?

That shift matters.

A reference should no longer be treated as a bibliographic decoration.

It should be treated as a claim about a source.

That claim should be checked against trusted source records, including:

DOI or PMID;

title;

authors;

journal;

publication date;

version;

publisher record;

correction status;

retraction status;

source accessibility.

This verification should not happen after publication.

It should happen when the citation enters the AI-assisted workflow.

Before submission.

Before editorial review.

Before publication.

Before downstream reuse.

The standard has to move upstream.

Once a fabricated reference enters the published record, every downstream system inherits the problem.

Citation as text vs citation as evidence

Medical publishers need sharper language.

This distinction is central.

A formatted citation is not a verified source.

A plausible reference is not evidence.

A DOI-like string is not source integrity.

Medical publishers cannot defend trust with typography.

They need verification.

What a connected publishing catalogue makes visible

The question is not how to police every author manually.

That does not scale.

The better question is how to make the source layer observable at the point of AI use.

When a publisher’s catalogue is connected to the AI workflow, each claimed citation can be checked against trusted source records.

Every AI-assisted output can then generate an audit event:

claimed citation → matched source record → metadata verification → integrity status → workflow decision

That decision may be:

allowed;

flagged;

blocked;

sent for human review.

This would not eliminate every fraud pattern.

It would be dishonest to suggest otherwise. Determined misconduct will keep evolving.

But an observable source layer would make many phantom citations visible before they pass as formatted, plausible text.

A reference with no matching record should not move through a medical publishing workflow unnoticed.

That is the shift medical publishers need.

From citation as text.

To citation as evidence.

From plausible reference.

To provable source.

Retrieved is not cited — and cited is not verified

AI search adds another complication.

A source can be retrieved without being cited.

That creates a visibility problem for publishers.

But the reverse problem also matters in medical publishing:

A source can be cited without being verified.

That creates an integrity problem.

Both failures come from the same structural weakness: the workflow does not preserve enough evidence about source use.

This is why retrieved is not cited matters in the same evidence chain.

AI systems separate events that used to feel connected.

Retrieval.

Citation.

Verification.

Usage.

Attribution.

Source existence.

None of these should be assumed from the others.

A citation is not proof that a source was used.

A retrieval event is not proof that a source was cited.

A formatted reference is not proof that the source exists.

Each event needs its own record.

Provenance is necessary, but not sufficient

Provenance helps establish where content came from and how it has changed over time.

That matters for trust.

But citation integrity also needs usage evidence.

A source may be authentic and still misused.

A source may exist and still not support the claim.

A citation may point to a real article but mismatch the title, author list, date, version or conclusion.

That is why content provenance vs usage evidence is more than a licensing distinction.

It is also an editorial integrity distinction.

Provenance answers:

Is this source real and traceable?

Usage evidence answers:

Was this source used in this workflow, for this output, under these conditions?

Medical publishing needs both.

Origin without workflow evidence leaves a gap.

Workflow evidence without trusted source identity is weak.

What source verification should capture

A serious AI-assisted medical publishing workflow needs more than reference formatting.

It needs source verification records.

At minimum, a source verification event should capture:

the claimed citation;

the matched source record;

the DOI, PMID or other identifier;

metadata consistency;

source accessibility;

publication status;

version status;

correction or retraction status;

the AI workflow in which the source was used;

the decision taken by the system;

the human review status, if needed;

the date and time of verification.

This is the operational layer that turns citation checking into auditability.

Not a cosmetic feature.

Not a post-publication clean-up.

A workflow control.

Without it, publishers remain dependent on visual plausibility.

And visual plausibility is exactly what generative AI is good at faking.

Why proof of content use matters here too

It is tempting to treat fabricated citations as a separate problem from AI content licensing.

That would be a mistake.

Both issues depend on the same missing layer: records of source use.

In licensing, publishers need to know which content was used by AI systems to support pricing, attribution and renewal.

In medical publishing, publishers need to know which sources were used or claimed inside AI-assisted workflows to protect the integrity of the record.

Different commercial consequences.

Same evidence problem.

This is why proof of AI content usage belongs in this article.

A medical publisher cannot protect value or trust if it cannot verify source use.

The objection: reference checking already exists

There is a fair objection.

Reference checking tools already exist. Editorial teams already use DOI checks, Crossref tools, PubMed links, manuscript systems and production workflows.

True.

But the Lancet audit shows that existing processes are not enough.

The issue is not the absence of any checking.

The issue is the gap between available verification and workflow-level enforcement.

A fabricated reference can still move through the system if verification is optional, late, manual, incomplete or disconnected from AI-assisted drafting.

Medical publishers do not need another isolated checker.

They need source verification embedded into the workflow.

A citation that fails verification should not be treated as a formatting issue.

It should become a workflow event.

Flagged.

Logged.

Blocked or reviewed.

Auditable.

That is the standard AI-assisted publishing now requires.

What Citations Logic is built to document

Citations Logic is built around a simple premise:

In AI-assisted publishing, it is not enough to ask whether a source was mentioned.

Organizations need to know whether the source actually existed, was accessible, matched the cited metadata and was used in a traceable way at the point of AI use.

That is what Citations Logic is designed to document.

Not just citation presence.

Source verification.

Source accessibility.

Source usage.

Workflow traceability.

For medical publishers, this matters because trust cannot depend on plausible-looking references.

It has to depend on verifiable source records and auditable AI-assisted workflows.

The next standard is not citation confidence.

It is source verification before citation confidence.

The question every medical publisher should ask now

Before fabricated references become a recurring item in correction workflows, medical publishers should ask one uncomfortable question:

Can your team prove which cited sources were verified before they entered an AI-assisted workflow?

Not assumed.

Not formatted.

Not visually checked.

Verified.

Matched to a real source record.

Checked for metadata consistency.

Linked to an accessible version.

Logged as part of the workflow.

If the honest answer is no, the gap is not only an integrity issue.

It is a strategic one.

Because in medical publishing, the value you sell is confidence in the source.

And a citation you cannot verify is confidence you cannot defend.

Frequently asked questions

What are fabricated citations in medical publishing?

Fabricated citations are references that appear legitimate but point to sources that do not exist, cannot be verified, or do not match the cited metadata. They may include plausible titles, authors, journals, dates and identifiers, which makes them difficult to detect through visual review alone.

Why are fabricated references an AI citation integrity problem?

Generative AI can produce plausible-looking references without grounding them in real source records. The risk increases when AI-assisted writing, summarization or literature review tools are used upstream of submission, review or publication workflows.

How common are fabricated citations in biomedical literature?

A 2026 audit published in The Lancet examined 2.5 million biomedical papers from PubMed Central’s Open Access subset. It found that approximately one in 277 papers published in early 2026 contained at least one fabricated reference, compared with approximately one in 2,828 in 2023.

Why do fabricated citations pass through publishing workflows?

Many workflows still treat references as formatted text rather than verifiable source events. If a citation looks plausible and follows a recognizable format, it may pass without being checked against DOI, PMID, publisher metadata, version status, accessibility, or correction and retraction records.

How can medical publishers reduce fabricated citation risk?

Medical publishers can reduce risk by verifying claimed citations against trusted source registries before publication and before downstream reuse. A source verification workflow should check identifiers, metadata, publication status, accessibility, versioning and integrity signals.

Is source verification enough to eliminate citation fraud?

No. Source verification will not eliminate every fraud pattern. But it can make phantom citations visible earlier, especially references that have no matching source record or inconsistent metadata. It turns citation checking from a manual visual process into an auditable workflow control.

Continue the evidence chain

AI Usage Evidence for Publishers

Machine-Readable Provenance for Reference Publishers

Retrieved Is Not Cited

AI Disclosure Is Not an Audit Trail for STM Publishers

Content Provenance vs Usage Evidence

Proof of AI Content Usage

Book an AI usage evidence assessment

Sources

The Lancet — “Fabricated citations: an audit across 2.5 million biomedical papers”
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00603-3/fulltext

Columbia University School of Nursing — “Nearly 3,000 peer-reviewed medical papers have fake citations, a Columbia Nursing AI-assisted audit finds”
https://www.nursing.columbia.edu/news/nearly-3-000-peer-reviewed-medical-papers-have-fake-citations-columbia-nursing-ai-assisted-audit-finds

Nature — “Surge in fake citations uncovered by audit of 2.5 million biomedical-science papers”
https://www.nature.com/articles/d41586-026-00748-w

PubMed — Nature article record: “Surge in fake citations uncovered by audit of 2.5 million biomedical-science papers”
https://pubmed.ncbi.nlm.nih.gov/42104128/

Retraction Watch — “One in 277 PubMed-indexed papers in 2026 shows fabricated references, says analysis”
https://retractionwatch.com/2026/05/07/one-in-277-pubmed-indexed-papers-in-2026-shows-fabricated-references-says-analysis/